Gene · 3822
Papers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT. | Blood Adv | 2023 | 37196646 | PubTator, text mining | PubMed |
| Transcriptomic Approaches in Studies on and Applications of Chimeric Antigen Receptor T Cells. | Biomedicines | 2023 | 37189725 | PubTator, text mining | PubMed |
| Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction. | Front Immunol | 2023 | 37187736 | PubTator, text mining | PubMed |
| Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas. | Int J Mol Sci | 2023 | 37176035 | PubTator, text mining | PubMed |
| Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors. | MAbs | 2023 | 37165468 | PubTator, text mining | PubMed |
| The single-cell transcriptional landscape of innate and adaptive lymphocytes in pediatric-onset colitis. | Cell Rep Med | 2023 | 37160121 | PubTator, text mining | PubMed |
| CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy. | Cancer Cell Int | 2023 | 37158883 | PubTator, text mining | PubMed |
| NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma. | Hemasphere | 2023 | 37153876 | PubTator, text mining | PubMed |
| Facing challenges with hope: universal immune cells for hematologic malignancies. | Cancer Biol Med | 2023 | 37144558 | PubTator, text mining | PubMed |
| Innate immunity and nonalcoholic fatty liver disease. | Ann Gastroenterol | 2023 | 37144011 | PubTator, text mining | PubMed |
| Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics. | Br J Cancer | 2023 | 37117649 | PubTator, text mining | PubMed |
| Human leukocyte antigen and tumor immunotherapy (Review). | Int J Oncol | 2023 | 37114561 | PubTator, text mining | PubMed |
| Recombinant Human Interleukin-2 Corrects NK Cell Phenotype and Functional Activity in Patients with Post-COVID Syndrome. | Pharmaceuticals (Basel) | 2023 | 37111294 | PubTator, text mining | PubMed |
| Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients. | Cancer Immunol Immunother | 2023 | 37081323 | PubTator, text mining | PubMed |
| Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells. | Front Immunol | 2023 | 37051244 | PubTator, text mining | PubMed |
| Emerging Targeted Therapies for HER2-Positive Breast Cancer. | Cancers (Basel) | 2023 | 37046648 | PubTator, text mining | PubMed |
| Cellular and molecular biomarkers of long COVID: a scoping review. | EBioMedicine | 2023 | 37037165 | PubTator, text mining | PubMed |
| Influence of killer immunoglobulin-like receptors genes on the recurrence rate of ocular toxoplasmosis in Brazil. | Mem Inst Oswaldo Cruz | 2023 | 37018796 | PubTator, text mining | PubMed |
| Editorial: Natural killer cell plasticity and diversity in antiviral immunity. | Front Immunol | 2023 | 36999011 | PubTator, text mining | PubMed |
| Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencing. | Emerg Microbes Infect | 2023 | 36987861 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3822/papers?page=19